Cargando…
Severe sequelae in bilateral acute iris transillumination syndrome secondary to the use of oral moxifloxacin: a case report
BACKGROUND: Moxifloxacin is a fourth-generation fluoroquinolone used as a second-line treatment for multiple bacterial infections. Uveitis has been described as an adverse effect related to this medication. Although several case reports have been published describing uveitis and bilateral acute iris...
Autores principales: | Rivera-Valdivia, Nicolás, Arteaga-Rivera, Karla, Reyes-Guanes, Juliana, Neira-Segura, Natalia, de-la-Torre, Alejandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449864/ https://www.ncbi.nlm.nih.gov/pubmed/34537056 http://dx.doi.org/10.1186/s13256-021-03075-y |
Ejemplares similares
-
Moxifloxacin and bilateral acute iris transillumination
por: Knape, Robert M, et al.
Publicado: (2013) -
Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose
por: Mendez Bermudez, Israel J, et al.
Publicado: (2023) -
Bilateral Acute Iris Transillumination Syndrome after Topical Moxifloxacin/Dexamethasone Initially Misdiagnosed as Uveitis: Case Report
por: da Costa, Daniella Socci, et al.
Publicado: (2023) -
Bilateral acute iris transillumination: Case report
por: Degirmenci, Cumali, et al.
Publicado: (2016) -
Unilateral acute iris depigmentation and transillumination after glaucoma surgery with mitomycin application and intracameral moxifloxacin
por: Sánchez-Sánchez, Carmen, et al.
Publicado: (2020)